LANOXICAPS Drug Patent Profile
✉ Email this page to a colleague
When do Lanoxicaps patents expire, and what generic alternatives are available?
Lanoxicaps is a drug marketed by Glaxosmithkline Llc and is included in one NDA.
The generic ingredient in LANOXICAPS is digoxin. There are ten drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the digoxin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lanoxicaps
A generic version of LANOXICAPS was approved as digoxin by RISING on December 23rd, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LANOXICAPS?
- What are the global sales for LANOXICAPS?
- What is Average Wholesale Price for LANOXICAPS?
Summary for LANOXICAPS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 1 |
DailyMed Link: | LANOXICAPS at DailyMed |
Recent Clinical Trials for LANOXICAPS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mirati Therapeutics Inc. | Phase 1 |
US Patents and Regulatory Information for LANOXICAPS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-002 | Jul 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-001 | Jul 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-003 | Jul 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-004 | Sep 24, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LANOXICAPS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-002 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-001 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-004 | Sep 24, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-003 | Jul 26, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LANOXICAPS
See the table below for patents covering LANOXICAPS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 434971 | ⤷ Sign Up | |
Belgium | 825842 | ⤷ Sign Up | |
Germany | 2507635 | ⤷ Sign Up | |
Austria | A133175 | ⤷ Sign Up | |
Italy | 1233251 | PRERARATO FARMACEUTICO A BASE DI DIGOSSINA PER INGESTIONE ORALE (Digoxin solns in capsule form) | ⤷ Sign Up |
Luxembourg | 71894 | ⤷ Sign Up | |
Australia | 501549 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |